BioSpace News Archive

Azafaros B.V. announced it will present data from its PRONTO study in patients with GM1 and GM2 gangliosidosis at the 20th annual WORLDSymposium™ in San Diego from 4-9 February, a major international research conference on lysosomal disorders.

HEPHAISTOS-Pharma, a biotechnology company developing next generation immunotherapies against cancer, announced that it has raised a €2 million seed round to finance GMP transfer and advance its lead candidate towards the clinic.

Enthera Pharmaceuticals, a clinical-stage biotech company developing first-in-class antibody therapeutics targeting the Insulin Growth Factor Binding Protein family for selected inflammatory diseases, announced the appointment of Lisa M. Olson, Ph.D., as the company’s Chief Executive Officer.

Caliway Biopharmaceuticals announces that Australian Bellberry HREC has approved Caliway’s application to initiate CBL-514’s Pivotal Phase 3 study for subcutaneous fat reduction.

BeiGene, Ltd., a global biotechnology company, announced that Olivier Brandicourt, M.D. has been appointed to its Board of Directors.

Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and The Michael J. Fox Foundation for Parkinson’s Research, a non-profit organization dedicated to finding a cure for Parkinson’s disease, announced a research project to accelerate research on genetic risk factors associated with PD, specifically targeting the role of variants in the GBA gene.

Caris Life Sciences® announced that the company and collaborators within the Caris Precision Oncology Alliance™ will collectively present eight studies across four tumor types at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium, January 25-27, 2024 in San Francisco.

BD announced a collaboration agreement with Hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduced human error when conducting large-scale single-cell multiomics experiments.

First Wave BioPharma, Inc. today announced that it will present at the DealFlow MicroCap Conference, which will be held January 30 – February 1, 2024 at the Caesars Atlantic City Hotel & Casino, in Atlantic City, New Jersey.

Satellos Bioscience Inc. announced that Alan K. Jacobs, M.D., Chief Medical Officer, has left the Company to pursue other opportunities.